Schedule 13G ownership disclosure

Viridian Therapeutics Inc

Security class unavailable · CUSIP: 92790C104

Event date: 2021-02-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
363,284
Percent of class
6.9700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001645257-21-000001
Form type
SC 13G
Filer
Hawkes Bay Master Investors (Cayman) L.P.
CIK
CIK 1645257
Filed
Feb 19, 2021
Reporting period
Feb 09, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub